Table 4.
Parameter | HR | 95% CI | p | |
---|---|---|---|---|
Insurance status | ||||
Non-Medicaid insured | – | – | – | – |
Medicaid insured | 1.71 | 1.61 | 1.81 | < 0.001a |
Uninsured | 1.08 | 0.98 | 1.19 | 0.112 |
Year of diagnosis | ||||
2007–2010 | – | – | – | – |
2011–2013 | 0.787 | 0.748 | 0.83 | < 0.001a |
2014–2016 | 0.624 | 0.584 | 0.67 | < 0.001a |
Age of diagnosis | ||||
20–39 | – | – | – | – |
40–54 | 2.92 | 2.45 | 3.47 | < 0.001a |
55–64 | 6.13 | 5.16 | 7.28 | < 0.001a |
Race | ||||
White | – | – | – | – |
Black | 1.51 | 1.43 | 1.60 | < 0.001a |
Other races | 0.73 | 0.68 | 0.79 | < 0.001a |
Cancer site | ||||
Colorectal | – | – | – | – |
Lung | 1.23 | 1.13 | 1.33 | < 0.001a |
Breast | 0.67 | 0.62 | 0.73 | < 0.001a |
Cervical | 1.12 | 0.95 | 1.31 | 0.174 |
Ovarian | 0.83 | 0.70 | 0.97 | 0.018a |
Urinary/bladder | 1.37 | 1.22 | 1.53 | < 0.001a |
Hodgkin lymphoma | 1.20 | 0.98 | 1.47 | 0.071 |
Non-Hodgkin lymphoma | 0.99 | 0.89 | 1.09 | 0.819 |
Models were adjusted for patient’s gender, marital status, extent of cancer, cancer site, treatments including radiation therapy, chemotherapy, and surgery
a: Variables were tested statistically significant in multivariable Fine-Grey models